162 related articles for article (PubMed ID: 12360103)
1. Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease.
Furuno T; Landi MT; Ceroni M; Caporaso N; Bernucci I; Nappi G; Martignoni E; Schaeffeler E; Eichelbaum M; Schwab M; Zanger UM
Pharmacogenetics; 2002 Oct; 12(7):529-34. PubMed ID: 12360103
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease.
Droździk M; Białecka M; Myśliwiec K; Honczarenko K; Stankiewicz J; Sych Z
Pharmacogenetics; 2003 May; 13(5):259-63. PubMed ID: 12724617
[TBL] [Abstract][Full Text] [Related]
3. Frequency of common MDR1 gene variants in a Polish population.
Kurzawski M; Pawlik A; Górnik W; Droździk M
Pharmacol Rep; 2006; 58(1):35-40. PubMed ID: 16531628
[TBL] [Abstract][Full Text] [Related]
4. Analysis of MDR1 haplotypes in Parkinson's disease in a white population.
Tan EK; Drozdzik M; Bialecka M; Honczarenko K; Klodowska-Duda G; Teo YY; Tang K; Wong LP; Chong SS; Tan C; Yew K; Zhao Y; Lee CG
Neurosci Lett; 2004 Dec; 372(3):240-4. PubMed ID: 15542248
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of coding SNPs in blood-brain barrier transporter MDR1 in European Parkinson's disease patients.
Funke C; Soehn AS; Tomiuk J; Riess O; Berg D
J Neural Transm (Vienna); 2009 Apr; 116(4):443-50. PubMed ID: 19255821
[TBL] [Abstract][Full Text] [Related]
6. High baseline serum total and LDL cholesterol levels are associated with MDR1 haplotypes in Brazilian hypercholesterolemic individuals of European descent.
Rodrigues AC; Rebecchi IM; Bertolami MC; Faludi AA; Hirata MH; Hirata RD
Braz J Med Biol Res; 2005 Sep; 38(9):1389-97. PubMed ID: 16138223
[TBL] [Abstract][Full Text] [Related]
7. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.
Cascorbi I; Gerloff T; Johne A; Meisel C; Hoffmeyer S; Schwab M; Schaeffeler E; Eichelbaum M; Brinkmann U; Roots I
Clin Pharmacol Ther; 2001 Mar; 69(3):169-74. PubMed ID: 11240981
[TBL] [Abstract][Full Text] [Related]
8. Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients.
Anglicheau D; Verstuyft C; Laurent-Puig P; Becquemont L; Schlageter MH; Cassinat B; Beaune P; Legendre C; Thervet E
J Am Soc Nephrol; 2003 Jul; 14(7):1889-96. PubMed ID: 12819250
[TBL] [Abstract][Full Text] [Related]
9. Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene.
Kimchi-Sarfaty C; Marple AH; Shinar S; Kimchi AM; Scavo D; Roma MI; Kim IW; Jones A; Arora M; Gribar J; Gurwitz D; Gottesman MM
Pharmacogenomics; 2007 Jan; 8(1):29-39. PubMed ID: 17187507
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms and haplotypes in the multidrug resistance 1 gene (MDR1/ABCB1) and risk of multiple myeloma.
Jamroziak K; Balcerczak E; Calka K; Piaskowski S; Urbanska-Rys H; Salagacka A; Mirowski M; Robak T
Leuk Res; 2009 Feb; 33(2):332-5. PubMed ID: 18639335
[TBL] [Abstract][Full Text] [Related]
11. MDR1, the blood-brain barrier transporter, is associated with Parkinson's disease in ethnic Chinese.
Lee CG; Tang K; Cheung YB; Wong LP; Tan C; Shen H; Zhao Y; Pavanni R; Lee EJ; Wong MC; Chong SS; Tan EK
J Med Genet; 2004 May; 41(5):e60. PubMed ID: 15121788
[No Abstract] [Full Text] [Related]
12. Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations.
Tang K; Ngoi SM; Gwee PC; Chua JM; Lee EJ; Chong SS; Lee CG
Pharmacogenetics; 2002 Aug; 12(6):437-50. PubMed ID: 12172212
[TBL] [Abstract][Full Text] [Related]
13. Comparative description of haplotype structure and genetic diversity of MDR1 (ABCB1) in HIV-positive and HIV-negative populations.
Benish RL; Rodriguez B; Zimmerman PA; Mehlotra RK
Infect Genet Evol; 2010 Jan; 10(1):60-7. PubMed ID: 19819348
[TBL] [Abstract][Full Text] [Related]
14. Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1).
Hitzl M; Schaeffeler E; Hocher B; Slowinski T; Halle H; Eichelbaum M; Kaufmann P; Fritz P; Fromm MF; Schwab M
Pharmacogenetics; 2004 May; 14(5):309-18. PubMed ID: 15115917
[TBL] [Abstract][Full Text] [Related]
15. Effect of MDR1 haplotype on risk of Parkinson disease.
Tan EK; Chan DK; Ng PW; Woo J; Teo YY; Tang K; Wong LP; Chong SS; Tan C; Shen H; Zhao Y; Lee CG
Arch Neurol; 2005 Mar; 62(3):460-4. PubMed ID: 15767512
[TBL] [Abstract][Full Text] [Related]
16. Influence of MDR1 gene polymorphism (2677G>T) on expression and function of P-glycoprotein at the blood-brain barrier: utilizing novel P-glycoprotein humanized mice with mutation.
Yamasaki Y; Moriwaki T; Ogata S; Ito S; Ohtsuki S; Minegishi G; Abe S; Ohta Y; Kazuki K; Kobayashi K; Kazuki Y
Pharmacogenet Genomics; 2022 Oct; 32(8):288-292. PubMed ID: 35997049
[TBL] [Abstract][Full Text] [Related]
17. Human MDR1 polymorphism: G2677T/A and C3435T have no effect on MDR1 transport activities.
Morita N; Yasumori T; Nakayama K
Biochem Pharmacol; 2003 Jun; 65(11):1843-52. PubMed ID: 12781336
[TBL] [Abstract][Full Text] [Related]
18. MDR1 C3435T polymorphism and interaction with environmental factors in risk of Parkinson's disease: a case-control study in Japan.
Kiyohara C; Miyake Y; Koyanagi M; Fujimoto T; Shirasawa S; Tanaka K; Fukushima W; Sasaki S; Tsuboi Y; Yamada T; Oeda T; Shimada H; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M;
Drug Metab Pharmacokinet; 2013; 28(2):138-43. PubMed ID: 22971641
[TBL] [Abstract][Full Text] [Related]
19. [Polymorphism of human MDR1 gene in the Siberian and central Asian populations].
Pel's IaR; Marusin AV; Spiridonova MG; Stepanov VA
Mol Biol (Mosk); 2007; 41(6):982-8. PubMed ID: 18318115
[TBL] [Abstract][Full Text] [Related]
20. C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation.
Goto M; Masuda S; Saito H; Uemoto S; Kiuchi T; Tanaka K; Inui K
Pharmacogenetics; 2002 Aug; 12(6):451-7. PubMed ID: 12172213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
